J Cardiovasc Med 2012, 13: Received 19 October 2011 Revised 8 November 2011 Accepted 29 November 2011

Size: px
Start display at page:

Download "J Cardiovasc Med 2012, 13: Received 19 October 2011 Revised 8 November 2011 Accepted 29 November 2011"

Transcription

1 Systematic review The importance of exercise echocardiography for clinical decision making in primary mitral regurgitation Caroline M. Van de Heyning, Julien Magne, Patrizio Lancellotti and Luc A. Piérard Primary mitral regurgitation is generally an insidious disease with late onset of symptoms. Current European and American guidelines recommend surgery in severe primary mitral regurgitation when symptoms, overt left ventricular dysfunction, pulmonary hypertension or atrial fibrillation, occur. However, recent large studies reported an improved outcome in asymptomatic patients with severe mitral regurgitation referred for early mitral valve repair despite the risk of operative mortality or mitral valve replacement. Moreover, primary mitral regurgitation appears to have an important dynamic character in up to one-third of patients. This article provides an overview of the incremental evidence of the ability of exercise echocardiography to assess the functional repercussions of mitral regurgitation and the identification of high-risk patients who might benefit from early referral for surgery. J Cardiovasc Med 2012, 13: Keywords: exercise echocardiography, primary mitral regurgitation University of Liege, University Hospital Sart Tilman, Liege, Belgium Correspondence to Luc A. Piérard, MD, PhD, University Hospital Sart Tilman, Liege 400, Belgium Tel: ; fax: ; lpierard@chu.ulg.ac.be Received 19 October 2011 Revised 8 November 2011 Accepted 29 November 2011 Introduction Mitral regurgitation is the second most prevalent valvulopathy in Europe after aortic stenosis. 1 Primary mitral regurgitation has an organic cause such as rheumatic disease, myxomatous degeneration or endocarditis. In secondary mitral regurgitation, the mitral valve is structurally normal but dysfunctional due to ischaemic or non-ischaemic cardiomyopathy. The disease course of primary mitral regurgitation is usually insidious due to progressive atrial and left ventricular remodelling which compensates for the overload caused by the increasing regurgitant volume. 2 Although the late onset of symptoms often leads to late referral for surgery, 3 the outcome of medically treated asymptomatic severe primary mitral regurgitation remains unclear. Enriquez-Sarano et al. 4 reported a 5-year probability of 62 þ 8% for cardiac death, heart failure or new atrial fibrillation in asymptomatic patients with severe mitral regurgitation, whereas more recently Kang et al. 5 found a 7-year survival free of cardiac death or heart failure of 85 þ 4% in asymptomatic mitral regurgitation with a preserved left ventricular ejection fraction (LVEF). The 2007 European Society of Cardiology (ESC) and 2008 American College of Cardiology (ACC)/America Heart Association (AHA) guidelines recommend surgery in severe primary mitral regurgitation with symptoms including LVEF of 60% or less, left ventricular dilatation, atrial fibrillation and/or pulmonary hypertension (PHT) (Table 1). 6,7 Rosenhek et al. 8 showed an excellent outcome in asymptomatic severe mitral regurgitation with the watchful waiting strategy in accordance with these guidelines. Nevertheless, numerous large studies have provided evidence for a more favourable clinical course if patients are submitted to surgery before left ventricular dysfunction or PHT has developed It is well established that mitral valve repair yields a better prognosis than mitral valve replacement regarding operative mortality, postoperative LVEF and prosthesis-related complications. 2,3 Despite a low operative mortality risk of 0.6% for asymptomatic patients and increasing repairability rates, 13 it should be noted that there is a considerable variability in the frequency of mitral valve repair between high and low volume centres and surgeons. 3,14 As a result, a heated debate persists about the optimal timing for surgery Moreover degenerative mitral regurgitation appears to be a dynamic disease with significant progression of mitral regurgitation during exercise in one-third of patients, which is associated with a worse outcome. 18,19 Risk stratification to identify patients who could benefit from early surgery appears to be crucial in the current management of primary mitral regurgitation. In this setting, several recent articles have pointed out the emerging role of exercise echocardiography The most recent guidelines of the European Association of Echocardiography (EAE) 24 only recommend exercise echocardiography in primary mitral regurgitation when symptoms are discordant with mitral regurgitation severity at rest. This article will give an overview of the current utility of exercise echocardiography in clinical decision making. Exercise-induced haemodynamic changes in primary mitral regurgitation The dynamic character of secondary mitral regurgitation and its implications are well established. 25 Conversely, ß 2012 Italian Federation of Cardiology DOI: /JCM.0b013e c70

2 Exercise echocardiography in primary MR Van de Heyning et al. 261 Table 1 Surgical criteria for mitral valve repair in severe primary mitral regurgitation Surgical criterion 2007 ESC guidelines ACC/AHA guidelines 6 Symptomatic severe MR Class I Class I LVEF < 60% Class I Class I End-systolic diameter > 45 mm Class I End-systolic diameter > 40 mm Class I SPAP > 50 mmhg at rest Class IIa Class IIa SPAP > 60 mmhg at exercise Class IIa Atrial fibrillation Class IIa Class IIa High probability mitral valve Class IIb repair, low comorbidity Probability mitral valve repair >90%, expert centre Class IIa ACC, American College of Cardiology; AHA, American Heart Association; ESC, European Society of Cardiology; LVEF, left ventricular ejection fraction; MR, mitral regurgitation; SPAP, systolic pulmonary arterial pressure. few studies exist about exercise-induced changes in primary mitral regurgitation. Stoddard et al. 18 showed that 32% of patients with mitral valve prolapse without mitral regurgitation developed mitral regurgitation during exercise. More recently and in line with these data, Magne et al. 19 found an increase in mitral regurgitation (regurgitant volume > 15 ml or effective regurgitant orifice area > 10 mm 2 ) in one-third of asymptomatic patients with moderate-to-severe degenerative mitral regurgitation. Interestingly, according to the effective regurgitant orifice area, 32% of patients with moderate mitral regurgitation at rest developed severe mitral regurgitation at exercise, whereas, respectively, 15 and 7% of patients with severe and moderate mitral regurgitation dropped one class. Both studies observed in these patients an increased mitral valve annulus area which could point at exercise-induced progressive ring dilatation with suboptimal leaflet coaptation as a possible mechanism. The smaller cavity during exercise with subsequent less tugging of the chordae and, thus, worsening mitral valve prolapse might be an additional factor in degenerative mitral regurgitation. 19 The rise in blood pressure during exercise did not seem to play a major role in increasing mitral regurgitation in the latter study. Importantly, there was a strong correlation between exercise-induced mitral regurgitation progression and exercise PHT. How to perform exercise echocardiography in primary mitral regurgitation First, the patients medical history and a directed physical examination should be obtained to identify symptoms. Second, a rest echocardiography should be performed according to the guidelines 26,27 to identify and localize the valvular lesion and to quantify mitral regurgitation severity, LVEF, left ventricular dimensions (especially the left ventricular end-systolic diameter) and the systolic pulmonary arterial pressure (SPAP). Subsequently, exercise echocardiography is recommended in asymptomatic patients with severe mitral regurgitation or in symptomatic patients with less-than-severe mitral regurgitation in order to assess the haemodynamic consequences of mitral regurgitation. Continuous echocardiographic examination during semisupine ergometry is preferred over postexercise echocardiography, as measurements can differ significantly between peak stress and the immediate postexercise period, 22 specifically regarding the SPAP. After the patient is positioned on the ergometer, a workload of 50 W is set. During the test, the workload is increased with 25 W every 3 min in young, otherwise healthy patients, but can be adjusted in older individuals. Heart rate, blood pressure and symptoms should be noted at each level and during recovery, as well as exercise duration (Fig. 1). Meanwhile, image acquisition is performed with special attention to the systolic left ventricular function, the evolution of mitral regurgitation severity and the SPAP. Data from expert echo laboratories show a high feasibility and reproducibility of mitral regurgitation quantification and a good agreement between the flow convergence method and the Doppler volumetric method both at rest and during exercise, 19,28 although this assessment might be challenging in less experienced hands. 23 Exercise echocardiography is not recommended in severe mitral regurgitation with symptoms or a LVEF less than 60% (indications for surgery), severe hypertension, important arrhythmias, systemic illness or the impossibility to perform an adequate exercise test. 22 Assessment of functional repercussions of mitral regurgitation As in non-valvular cardiac abnormality, 29 diastolic dysfunction appears to be a major determinant in reduced functional capacity in primary mitral regurgitation, Fig. 1 Setting semisupine ergometer in exercise echocardiography. Echocardiographic images are acquired at rest, during several steps of exercise and during recovery. Meanwhile, continuous 12-lead ECG recording is performed and blood pressure and symptoms are noted at each step.

3 262 Journal of Cardiovascular Medicine 2012, Vol 13 No 4 regardless of compensatory left atrial dilatation. 30,31 Moreover, resting left ventricular filling pressures may predict exercise PHT 32 which is correlated with a decreased exercise capacity. 33 To a lesser extent, reduction of exercise tolerance is associated with a lower exercise cardiac output, 31 caused by the inability of the left ventricle to maintain a large forward stroke volume. Exercise forward stroke volume in mitral regurgitation is determined by two opposing mechanisms, namely contractile reserve and eventually increasing mitral regurgitation. 23 The presence of contractile reserve itself is associated with a significantly better functional capacity in comparison with lack of contractile reserve. 34 Due to the slow disease progression, the patient may be unaware of their adaptation of daily activities and will often deny symptoms. It is well recognized that there is a primary role for exercise testing to unmask these asymptomatic patients. 35 Current EAE guidelines advocate exercise echocardiography when symptoms are discrepant with mitral regurgitation severity at rest. 24,26 These recommendations are based on a small study by Tischler et al. 36 which found that exertional dyspnoea in mild rheumatic valve disease is frequently explained by an increase in mitral regurgitation combined with exercise PHT. This observation was recently confirmed by a study in 78 asymptomatic patients with moderate-to-severe degenerative mitral regurgitation in which patients with exercise-induced increase in mitral regurgitation had higher SPAP, more frequent exercise PHT and presented more often dyspnoea during exercise 33 (Fig. 2). In brief, there is incremental evidence that exercise echocardiography is an interesting tool for the objective evaluation of the functional repercussions of mitral regurgitation. Identification of high-risk patients There is not yet a consensus about the optimal timing for surgery in asymptomatic patients with severe mitral regurgitation and preserved left ventricular systolic function. Although a LVEF less than 60% is highly predictive for postoperative left ventricular deterioration, 9 a decreased LVEF is only a late marker of left ventricular dysfunction in significant primary mitral regurgitation. Indeed, in these patients, the LVEF remains generally normal or supranormal due to the increased preload and the alternative low impedance pathway provided by the regurgitant orifice. 37,38 Detection of subclinical systolic left ventricular dysfunction in patients with severe mitral regurgitation is, therefore, mandatory to avoid postoperative overt left ventricular impairment. In recent years, exercise echocardiography has become an important tool for this purpose. 39 The absence of contractile reserve, initially defined as less than 4% increase in the LVEF at exercise, predicts a worse postoperative LVEF and event-free survival in minimally symptomatic severe mitral regurgitation patients submitted to surgery. 34,40 Fig. 2 Example of an exercise echocardiogram in a 78-year-old male patient with severe primary mitral regurgitation and a normal ejection fraction of 67%. The first column represents images at rest of, respectively, the colour flow mapping of the mitral regurgitation, the velocity time integral of the regurgitant jet and the transtricuspid gradient (both measured by continuous Doppler). The second column depicts the same images during exercise and shows a slight increase in the effective regurgitant orifice (from 40 to 46 mm 2 ) and the regurgitant volume (from 63 to 72 ml) with concomitant increase of the systolic pulmonary arterial pressure (increase of the transtricuspid gradient from 55 to 74 mmhg). Alternatively, contractile reserve can be assessed by two-dimensional speckle-tracking whereby less than 1.9% increase in global longitudinal strain (GLS) at peak exercise predicts postoperative left ventricular deterioration in asymptomatic patients 41 (Fig. 3). Recent data from our echocardiography laboratory show that evaluation of contractile reserve by GLS is more accurate than by ejection fraction in predicting adverse outcome (accepted abstract ESC Congress 2011). Contractile reserve can also be appreciated by pharmacological stress testing, its only indication in primary mitral regurgitation. 24 Apart from revealing early left ventricular dysfunction, exercise echocardiography is also useful for identification of several risk factors which yield a poor outcome. First, it has been shown that decreased exercise capacity itself, marked by a reduced peak oxygen consumption during cardiopulmonary exercise testing 31 or a diminished duration at exercise tolerance test, 42 is predictive for mortality and the development of symptoms or other criteria for surgery in asymptomatic mitral regurgitation. Second, both exercise PHT (>60 mmhg) 33 and exerciseinduced increase in mitral regurgitation severity 19 have recently been shown to be strongly correlated with a

4 Exercise echocardiography in primary MR Van de Heyning et al. 263 Fig. 3 Absence of contractile reserve in a patient with severe primary mitral regurgitation. The upper panel represents two-dimensional strain calculations at rest for the patient also used for Fig. 2. The lower figure shows the two-dimensional strain values during exercise. Despite an increase in mitral regurgitation and ejection fraction, there was almost no increase in global longitudinal strain (23.7% at rest versus 24.0% during exercise), indicating subclinical left ventricular dysfunction.

5 264 Journal of Cardiovascular Medicine 2012, Vol 13 No 4 decreased symptom-free survival. On the basis of these data, the 2010 EAE recommendations 26 state that the absence of contractile reserve, a limited exercise capacity, the presence of exercise PHT or an exercise-induced increase in mitral regurgitation severity may identify high-risk patients who might benefit from early surgery. At least a closer follow-up should be provided in these high-risk patients, as in patients who almost fulfil the surgical criteria. The 2008 ACC/AHA guidelines 6 already adopted exercise PHT more than 60 mmhg as a class IIa indication for surgery. However, it should be noted that over one-third of normal individuals older than 60 years present PHT of at least 60 mmhg at peak exercise, 43 and that exercise PHT can be predicted by age and rest echocardiographic parameters. 32 Conclusion In patients with primary mitral regurgitation, current guidelines support the use of exercise echocardiography in patients with discordant symptoms, to evaluate the functional repercussion of mitral regurgitation in an objective manner. Like secondary mitral regurgitation, primary mitral regurgitation appears to be a dynamic condition which is incompletely characterized at rest. Recent studies show that limited exercise capacity and exercise-induced mitral regurgitation progression or exercise PHT are correlated with the development of symptoms. Furthermore, there is growing evidence that exercise echocardiography should be performed on a regular basis in asymptomatic patients with severe mitral regurgitation to detect absence of contractile reserve which points at subclinical left ventricular dysfunction. Implementation of exercise echocardiography in asymptomatic severe primary mitral regurgitation permits a more precise identification of patients who require a closer follow-up and who might benefit from early referral for surgery. Watchful waiting seems more appropriate in patients without the above-mentioned risk factors or when mitral valve repair is unlikely. References 1 Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J 2003; 24: Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet 2009; 373: Anyanwu AC, Bridgewater B, Adams DH. The lottery of mitral valve repair surgery. Heart 2010; 96: Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005; 352: Kang DH, Kim JH, Rim JH, et al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation 2009; 119: Bonow RO, Carabello BA, Chatterjee K, et al focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52:e1 e Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 2006; 113: Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994; 90: Tribouilloy C, Grigioni F, Avierinos JF, et al. Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. J Am Coll Cardiol 2009; 54: Barbieri A, Bursi F, Grigioni F, et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a Multicenter Long-term International Study (on behalf of the Mitral Regurgitation International DAtabase (MIDA) Investigators). Eur Heart J 2011; 32: Le Tourneau T, Richardson M, Juthier F, et al. Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart 2010; 96: Gammie JS, Sheng S, Griffith BP, et al. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2009; 87: Bolling SF, Li S, O Brien SM, Brennan JM, Prager RL, Gammie JS. Predictors of mitral valve repair: clinical and surgeon factors. Ann Thorac Surg 2010; 90: Enriquez-Sarano M, Sundt TM. Early surgery is recommended for mitral regurgitation. Circulation 2010; 121: Gillam LD, Schwartz A. Primum non nocere: the case for watchful waiting in asymptomatic severe degenerative mitral regurgitation. Circulation 2010; 121: Suri RM, Avierinos JF, Dearani JA, et al. Management of less-than-severe mitral regurgitation: should guidelines recommend earlier surgical intervention? Eur J Cardiothorac Surg 2011; 40: Stoddard MF, Prince CR, Dillon S, Longaker RA, Morris GT, Liddell NE. Exercise-induced mitral regurgitation is a predictor of morbid events in subjects with mitral valve prolapse. J Am Coll Cardiol 1995; 25: Magne J, Lancellotti P, Piérard LA. Exercise-induced changes in degenerative mitral regurgitation. J Am Coll Cardiol 2010; 56: Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol 2009; 54: Yared K, Lam KM, Hung J. The use of exercise echocardiography in the evaluation of mitral regurgitation. Curr Cardiol Rev 2009; 5: O Connor K, Lancellotti P, Piérard LA. Stress Doppler echocardiography in valvular heart diseases: utility and assessment. Future Cardiol 2010; 6: Flachskampf FA. Mitral regurgitation is incompletely characterized at rest. J Am Coll Cardiol 2010; 56: Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2008; 9: Lancellotti P, Gérard PL, Piérard LA. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 2005; 26: Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: Mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010; 11: Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with twodimensional and Doppler echocardiography (American Society of Echocardiography). J Am Soc Echocardiogr 2003; 16: Enriquez-Sarano M, Miller FA, Hayes SN, Bailey KR, Tajik AJ, Seward JB. Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method. J Am Coll Cardiol 1995; 25: Montant P, Chenot F, Robert A, et al. Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: a propensity score-based comparison between an early surgical strategy and a conservative treatment approach. J Thorac Cardiovasc Surg 2009; 138:

6 Exercise echocardiography in primary MR Van de Heyning et al Kim HK, Kim YJ, Chung JW, Sohn DW, Park YB, Choi YS. Impact of left ventricular diastolic function on exercise capacity in patients with chronic mitral regurgitation: an exercise echocardiography study. Clin Cardiol 2004; 27: Messika-Zeitoun D, Johnson BD, Nkomo V, et al. Cardiopulmonary exercise testing determinationoffunctionalcapacityinmitralregurgitation: physiologic and outcome implications. J Am Coll Cardiol 2006; 47: Magne J, Lancellotti P, O Connor K, Van de Heyning CM, Szymanski C, Piérard LA. Prediction of exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. J Am Soc Echocardiogr 2011; 24: Magne J, Lancellotti P, Piérard LA. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 2010; 122: Lee R, Haluska B, Leung DY, Case C, Mundy J, Marwick TH. Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation. Heart 2005; 91: Piérard LA, Lancellotti P. Stress testing in valve disease. Heart 2007; 93: Tischler MD, Battle RW, Saha M, Niggel J, LeWinter MM. Observations suggesting a high incidence of exercise-induced severe mitral regurgitation in patients with mild rheumatic mitral valve disease at rest. J Am Coll Cardiol 1995; 25: de Isla LP, De Agustin A, Rodrigo JL, et al. Chronic mitral regurgitation: a pilot study to assess preoperative left ventricular contractile function using speckle-tracking echocardiography. J Am Soc Echocardiogr 2009; 22: Hetzer R, Dandel M. Early detection of left ventricular dysfunction in patients with mitral regurgitation due to flail leaflet is still a challenge. Eur Heart J 2011; 32: Lee R, Marwick TH. Assessment of subclinical left ventricular dysfunction in asymptomatic mitral regurgitation. Eur J Echocardiogr 2007; 8: Leung DY, Griffin BP, Stewart WJ, Cosgrove DM, Thomas JD, Marwick TH. Left ventricular function after valve repair for chronic mitral regurgitation: predictive value of preoperative assessment of contractile reserve by exercise echocardiography. J Am Coll Cardiol 1996; 28: Lancellotti P, Cosyns B, Zacharakis D, et al. Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking. JAm Soc Echocardiogr 2008; 21: Supino PG, Borer JS, Schuleri K, et al. Prognostic value of exercise tolerance testing in asymptomatic chronic nonischemic mitral regurgitation. Am J Cardiol 2007; 100: Mahjoub H, Levy F, Cassol M, et al. Effects of age on pulmonary artery systolic pressure at rest and during exercise in normal adults. Eur J Echocardiogr 2010; 10:

Primary Mitral Regurgitation

Primary Mitral Regurgitation EURO VALVE Madrid News from Valves Guidelines 2012: What s new and Why? Primary Mitral Regurgitation Luc A. Pierard, MD, PhD Professor of Medicine Head of the Department of Cardiology Heart Valve Clinic,

More information

Assessing Function by Echocardiography in VHD Asymptomatic Severe Organic MR. Dr. Julien Magne, PhD Sart Tilman Liège, BELGIUM

Assessing Function by Echocardiography in VHD Asymptomatic Severe Organic MR. Dr. Julien Magne, PhD Sart Tilman Liège, BELGIUM Assessing Function by Echocardiography in VHD Asymptomatic Severe Organic MR Dr. Julien Magne, PhD Sart Tilman Liège, BELGIUM Conflict of Interest Disclosure None Why to assess LV function in asymptomatic

More information

What is the Role of Surgical Repair in 2012

What is the Role of Surgical Repair in 2012 What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th

More information

Advanced Evaluation of Left Ventricular Function in Degenerative MR. Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium

Advanced Evaluation of Left Ventricular Function in Degenerative MR. Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium Advanced Evaluation of Left Ventricular Function in Degenerative MR Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium Conflict of Interest Disclosure None Case Clinical data Previous

More information

Exercise-Induced Changes in Degenerative Mitral Regurgitation

Exercise-Induced Changes in Degenerative Mitral Regurgitation Journal of the American College of Cardiology Vol. 56, No. 4, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.12.073

More information

Chronic Primary Mitral Regurgitation

Chronic Primary Mitral Regurgitation Chronic Primary Mitral Regurgitation The Case For Early Surgical Intervention William K. Freeman, MD, FACC, FASE DISCLOSURES Relevant Financial Relationship(s) None Off Label Usage None Watchful Waiting......

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines Christophe Tribouilloy Amiens, France I have no financial relationships to disclose related

More information

Les valvulopathies en sourdine: la valve mitrale Quoi faire devant une régurgitation mitrale sévère asymptomatique de type dégénérative?

Les valvulopathies en sourdine: la valve mitrale Quoi faire devant une régurgitation mitrale sévère asymptomatique de type dégénérative? Réunion d automne de la SSC à Lucerne le 24.11.2011 Incertitudes dans le travail cardiologique quotidien Les valvulopathies en sourdine: la valve mitrale Quoi faire devant une régurgitation mitrale sévère

More information

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? Prof. Patrizio LANCELLOTTI, MD, PhD GIGA Cardiovascular Sciences, Heart Valve Clinic, University of Liège, CHU

More information

Spotlight on Valvular Heart Disease Guidelines

Spotlight on Valvular Heart Disease Guidelines Spotlight on Valvular Heart Disease Guidelines Aortic Valve Disease Raphael Rosenhek Department of Cardiology Medical University of Vienna Palermo, April 26 th 2018 1998 2002 2006 2007 2008 2012 2014 2017

More information

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,

More information

Ann Thorac Cardiovasc Surg 2015; 21: Online April 18, 2014 doi: /atcs.oa Original Article

Ann Thorac Cardiovasc Surg 2015; 21: Online April 18, 2014 doi: /atcs.oa Original Article Ann Thorac Cardiovasc Surg 2015; 21: 53 58 Online April 18, 2014 doi: 10.5761/atcs.oa.13-00364 Original Article The Impact of Preoperative and Postoperative Pulmonary Hypertension on Long-Term Surgical

More information

Author Proof. [3]. Exercise testing is strongly advocated in the European Society of Cardiology (ESC) guidelines

Author Proof. [3]. Exercise testing is strongly advocated in the European Society of Cardiology (ESC) guidelines Stress testing in valvular heart disease: clinical benefit of echocardiographic imaging Monica Roşca 1,2, Patrizio Lancellotti 1, Julien Magne 1 and Luc A Piérard 1 1 Department of Cardiology, University

More information

Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation

Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation Julien Magne, PhD, Kim O Connor, MD, Giuseppe Romano, MD, Marie Moonen, MD, Luc A.

More information

Valvular Guidelines: The Past, the Present, the Future

Valvular Guidelines: The Past, the Present, the Future Valvular Guidelines: The Past, the Present, the Future Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital Editor-in-Chief,

More information

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated? Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should

More information

Failure of Guideline Adherence for Intervention in Patients With Severe Mitral Regurgitation

Failure of Guideline Adherence for Intervention in Patients With Severe Mitral Regurgitation Journal of the American College of Cardiology Vol. 54, No. 9, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.03.079

More information

Natural History and Echo Evaluation of Aortic Stenosis

Natural History and Echo Evaluation of Aortic Stenosis Natural History and Echo Evaluation of Aortic Stenosis Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM AORTIC STENOSIS First valvular disease

More information

How to assess ischaemic MR?

How to assess ischaemic MR? ESC 2012 How to assess ischaemic MR? Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology University Hospital Sart Tilman, Liège ESC 2012 No conflict of interest Luc

More information

Asymptomatic Valvular Disease:

Asymptomatic Valvular Disease: Asymptomatic Valvular Disease: Can Echocardiography Help You Decide When to Intervene? Neil J. Weissman, MD MedStar Health Research Inst at MedStar Washington Hospital Center & Professor of Medicine Georgetown

More information

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction Role of Stress Echo in Valvular Heart Disease ECHO HAWAII January 15 19, 2018 Kenya Kusunose, MD, PhD, FASE Tokushima University Hospital Japan Not only ischemia! Cardiomyopathy Prosthetic Valve Diastolic

More information

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Disclosures: GE stock, Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Athena Poppas, MD FACC Past ACC Scientific Sessions Chair, ACC Board

More information

Indicator Mild Moderate Severe

Indicator Mild Moderate Severe Indicator Mild Moderate Severe Jet velocity (m/s) 2.0-2.9 3.0-3.9 4.0 Mean gradient (mmhg) < 20 20-39 40 Valve area (cm 2 ) 1.0 Valve area index (cm 2 /m 2 ) 0.6 1 Abnormal AV with Reduced Systolic Opening

More information

Imaging. Exercise Pulmonary Hypertension in Asymptomatic Degenerative Mitral Regurgitation

Imaging. Exercise Pulmonary Hypertension in Asymptomatic Degenerative Mitral Regurgitation Imaging Exercise Pulmonary Hypertension in Asymptomatic Degenerative Mitral Regurgitation Julien Magne, PhD; Patrizio Lancellotti, MD, PhD, FESC; Luc A. Piérard, MD, PhD, FESC Background Current guidelines

More information

Journal of the American College of Cardiology Vol. 42, No. 3, by the American College of Cardiology Foundation ISSN /03/$30.

Journal of the American College of Cardiology Vol. 42, No. 3, by the American College of Cardiology Foundation ISSN /03/$30. Journal of the American College of Cardiology Vol. 42, No. 3, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00649-1

More information

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun Clinical Outcome of Tricuspid Regurgitation David Messika-Zeitoun I have financial relationships to disclose Consultant for: Edwards, Symetis and Valtech Tricuspid Regurgitation is a Common Finding Tricuspid

More information

Improving Quality of Care for Patients with Heart Valve Disease

Improving Quality of Care for Patients with Heart Valve Disease Improving Quality of Care for Patients with Heart Valve Disease The Heart Team The Heart Valve Clinic Raphael Rosenhek Department of Cardiology Medical University of Vienna Eurovalve 2016 Brussels, March

More information

The New England Journal of Medicine. Clinical Practice. Diagnosis. Echocardiography

The New England Journal of Medicine. Clinical Practice. Diagnosis. Echocardiography Clinical Practice This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines,

More information

Exercise Testing/Echocardiography in Asymptomatic AS

Exercise Testing/Echocardiography in Asymptomatic AS Exercise Testing/Echocardiography in Asymptomatic AS Raluca Dulgheru, MD Heart Valve Clinic, University of Liège, CHU Sart Tilman, BELGIUM Disclosure related to this presentation: None VALVULAR HEART DISEASE

More information

The role of multi-imaging modality in primary mitral regurgitation

The role of multi-imaging modality in primary mitral regurgitation European Journal of Echocardiography Advance Access published November 29, 2011 European Journal of Echocardiography doi:10.1093/ejechocard/jer257 REVIEW The role of multi-imaging modality in primary mitral

More information

Severe left ventricular dysfunction and valvular heart disease: should we operate?

Severe left ventricular dysfunction and valvular heart disease: should we operate? Severe left ventricular dysfunction and valvular heart disease: should we operate? Laurie SOULAT DUFOUR Hôpital Saint Antoine Service de cardiologie Pr A. COHEN JESFC 16 janvier 2016 Disclosure : No conflict

More information

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

Valvular Regurgitation: Can We Do Better Than Colour Doppler? Valvular Regurgitation: Can We Do Better Than Colour Doppler? A/Prof David Prior St Vincent s Hospital Melbourne Sports Cardiology Valvular Regurgitation Valve regurgitation volume loads the ventricles

More information

Valvular Heart Disease

Valvular Heart Disease Valvular Heart Disease Roman M. Sniecinski, MD, FASE Associate Professor of Anesthesiology Emory University School of Medicine Learning Objectives Review the major pathophysiology of the most common heart

More information

Guidelines in perspective?

Guidelines in perspective? EuroValve 2016 Challenges in the management Secondary MR Guidelines in perspective? Luc A. Pierard, MD, PhD Professor of Medicine Head of the Department of Cardiology, Liège, Belgium Heart Valve Clinic,

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/38522 holds various files of this Leiden University dissertation. Author: Ewe, See Hooi Title: Aortic valve disease : novel imaging insights from diagnosis

More information

Asymptomatic Severe Aortic Stenosis with Left Ventricular Dysfunction: Watchful Waiting or Valve Replacement?

Asymptomatic Severe Aortic Stenosis with Left Ventricular Dysfunction: Watchful Waiting or Valve Replacement? CM&R Rapid Release. Published online ahead of print April 12, 2013 as Perspective Asymptomatic Severe Aortic Stenosis with Left Ventricular Dysfunction: Watchful Waiting or Valve Replacement? Larry E.

More information

The difficult patient with mitral regurgitation

The difficult patient with mitral regurgitation Clinical pathways The difficult patient with mitral regurgitation Stress echo can be the best tool Challenging cases Maria João Andrade, Lisbon PT Management of Severe Chronic Organic MR Echo Exercise

More information

Survival Implication of Left Ventricular End-Systolic Diameter in Mitral Regurgitation Due to Flail Leaflets

Survival Implication of Left Ventricular End-Systolic Diameter in Mitral Regurgitation Due to Flail Leaflets Journal of the American College of Cardiology Vol. 54, No. 21, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.06.047

More information

Cardiopulmonary Exercise Testing Determination of Functional Capacity in Mitral Regurgitation Physiologic and Outcome Implications

Cardiopulmonary Exercise Testing Determination of Functional Capacity in Mitral Regurgitation Physiologic and Outcome Implications Journal of the American College of Cardiology Vol. 47, No. 12, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.02.043

More information

Early Surgery in Asymptomatic Severe Aortic Stenosis Pros and Cons

Early Surgery in Asymptomatic Severe Aortic Stenosis Pros and Cons Early Surgery in Asymptomatic Severe Aortic Stenosis Pros and Cons Duk-Hyun Kang, M.D. Division of Cardiology Asan Medical Center Seoul, Korea Background Dilemma of balancing the risks versus benefits

More information

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic Load and Function - Valvular Heart Disease Tom Marwick, Cardiovascular Imaging Cleveland Clinic Indications for surgery in common valve lesions Risks Operative mortality Failed repair - to MVR Operative

More information

Mitral valve surgery has changed considerably in the past decades and is now indicated

Mitral valve surgery has changed considerably in the past decades and is now indicated Valve disease TIMING OF MITRAL VALVE SURGERY c POOR Correspondence to: Dr Maurice Enriquez-Sarano, Mayo Clinic, 2 First Street SW, Rochester, MN 5595, USA; sarano.maurice@mayo.edu Copyright 22 Mayo Foundation

More information

Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation

Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation Accepted Manuscript Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation Wobbe Bouma, MD PhD, Robert C. Gorman, MD PII: S0022-5223(18)32805-8

More information

Organic mitral regurgitation

Organic mitral regurgitation The best in heart valve disease Organic mitral regurgitation Ewa Szymczyk Department of Cardiology Medical University of Lodz, Poland I have nothing to declare Organic mitral regurgitation leaflet abnormality

More information

Mitral Regurgitation

Mitral Regurgitation Mitral Regurgitation Focus on Percutaneous Repair Steven J. Yakubov, MD FACC FSCAI System Chief, Structural Heart Diseaese, OhioHealth John H. McConnell Chair of Advanced Structural Heart Disease Medical

More information

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Late secondary TR after left sided heart disease correction: is it predictibale and preventable Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery Nath J, et al. JACC 2004 PREDICT Incidence of secondary

More information

Management of significant asymptomatic aortic stenosis. Alec Vahanian Bichat Hospital University Paris VII Paris, France

Management of significant asymptomatic aortic stenosis. Alec Vahanian Bichat Hospital University Paris VII Paris, France Management of significant asymptomatic aortic stenosis. Alec Vahanian Bichat Hospital University Paris VII Paris, France Background Aortic stenosis (AS) is the most frequent valve disease among referred

More information

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010 Bogdan A. Popescu University of Medicine and Pharmacy Bucharest, Romania EAE Course, Bucharest, April 2010 This is how it started Mitral stenosis at a glance 2D echo narrow diastolic opening of MV leaflets

More information

Gonçalo F. Coutinho, Ana Luís Garcia, Pedro M. Correia, Carlos Branco and Manuel J. Antunes*

Gonçalo F. Coutinho, Ana Luís Garcia, Pedro M. Correia, Carlos Branco and Manuel J. Antunes* European Journal of Cardio-Thoracic Surgery 48 (2015) 548 556 doi:10.1093/ejcts/ezu511 Advance Access publication 5 January 2015 ORIGINAL ARTICLE Cite this article as: Coutinho GF, Garcia AL, Correia PM,

More information

DECISION MAKING DEL CARDIOCHIRURGO NELL INSUFFICIENZA MITRALICA: ISTRUZIONI D USO D CARDIOLOGO

DECISION MAKING DEL CARDIOCHIRURGO NELL INSUFFICIENZA MITRALICA: ISTRUZIONI D USO D CARDIOLOGO DECISION MAKING DEL CARDIOCHIRURGO NELL INSUFFICIENZA MITRALICA: ISTRUZIONI D USO D PER IL CARDIOLOGO GUIDELINES IN ASYMPTOMATIC MR ACC/AHA ESC Antonio Miceli Heart Hospital Monasterio Foundation NATURAL/

More information

Effect of Mitral Inflow Pattern on Diagnosis of Severe Mitral Regurgitation in Patients with Chronic Organic Mitral Regurgitation

Effect of Mitral Inflow Pattern on Diagnosis of Severe Mitral Regurgitation in Patients with Chronic Organic Mitral Regurgitation http://dx.doi.org/10.4250/jcu.2013.21.4.165 without severe MR. 2) On the basis of a limited number of studies, American Society of Echocardiography (ASE) guidelines stated that, In severe MR without stenosis,

More information

Η ηχωκαρδιολογία στην διάγνωση κα πρόγνωση της καρδιακής ανεπάρκειας µε µειωµένο και φυσιολογικό κλάσµα εξώθησης

Η ηχωκαρδιολογία στην διάγνωση κα πρόγνωση της καρδιακής ανεπάρκειας µε µειωµένο και φυσιολογικό κλάσµα εξώθησης Η ηχωκαρδιολογία στην διάγνωση κα πρόγνωση της καρδιακής ανεπάρκειας µε µειωµένο και φυσιολογικό κλάσµα εξώθησης Βασίλειος Σαχπεκίδης Επιµελητής Β Καρδιολογίας Γ.Ν. Παπαγεωργίου Θεσσαλονίκη ESC Guidelines

More information

Degenerative mitral regurgitation (MR) is the second

Degenerative mitral regurgitation (MR) is the second Valvular Heart Disease Outcome of Watchful Waiting in Asymptomatic Severe Mitral Regurgitation Raphael Rosenhek, MD; Florian Rader, MD; Ursula Klaar, MD; Harald Gabriel, MD; Marcel Krejc, PhD; Daniel Kalbeck,

More information

Functional Mitral Regurgitation

Functional Mitral Regurgitation Club 35 - The best in heart valve disease - Functional Mitral Regurgitation Steven Droogmans, MD, PhD UZ Brussel, Jette, Belgium 08-12-2011 Euroecho & other Imaging Modalities 2011 No conflicts of interest

More information

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος MV anatomy Otto C. NEJM 2001 Leaflets anatomy 2% of population Etiology Terminology

More information

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with Echocardiography Guidelines for Valve and Chamber Quantification In partnership with Explanatory note & references These guidelines have been developed by the Education Committee of the British Society

More information

The Role of Ischemic Mitral Regurgitation in the Pathogenesis of Acute Pulmonary Edema

The Role of Ischemic Mitral Regurgitation in the Pathogenesis of Acute Pulmonary Edema The new england journal of medicine original article The Role of Ischemic Mitral Regurgitation in the Pathogenesis of Acute Pulmonary Edema Luc A. Piérard, M.D., Ph.D., and Patrizio Lancellotti, M.D. abstract

More information

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines - Reconstruction of the Aortic Valve and Root - A Practical Approach - Aortic Regurgitation and Aortic Aneurysm Wednesday 14 th September - 9.45 Practice must always be founded on sound theory. Leonardo

More information

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles

More information

Disclosures Rebecca T. Hahn, MD, FASE

Disclosures Rebecca T. Hahn, MD, FASE The New ASE Guidelines for Native Valvular Regurgitation Mitral Regurgitation The New ASE Guidelines: Role of 2D/3D and CMR (With caveats and comments from R. Hahn) William A. Zoghbi MD, FASE, MACC Professor

More information

Mitral valve regurgitation is a powerful factor of left ventricular hypertrophy

Mitral valve regurgitation is a powerful factor of left ventricular hypertrophy Original article Mitral valve regurgitation is a powerful factor of left ventricular hypertrophy Ewa Szymczyk, Karina Wierzbowska Drabik, Jarosław Drożdż, Maria Krzemińska Pakuła 2nd Chair and Department

More information

Chronic Mitral Regurgitation and Aortic Regurgitation

Chronic Mitral Regurgitation and Aortic Regurgitation Journal of the American College of Cardiology Vol. xx, No. x, 2013 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.08.1025

More information

Assessing the Impact on the Right Ventricle

Assessing the Impact on the Right Ventricle Advances in Tricuspid Regurgitation Congress of the European Society of Cardiology (ESC) Munich, August 25-29, 2012 Assessing the Impact on the Right Ventricle Stephan Rosenkranz, MD Clinic III for Internal

More information

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech Disclosures ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech Speaker s fee Edwards Lifesciences Sanofi-Aventis Decision Making in Patients with Multivalvular

More information

Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair

Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair Eric Lim, MBChB, MRCS; Clifford W. Barlow, DPhil, FRCS; A. Reza Hosseinpour, FRCS; Christopher Wisbey, BA; Kate Wilson, RN, BSc;

More information

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Dr Χρήστος ΑΛΕΞΙΟΥ MD, PhD, FRCS(Glasgow), FRCS(CTh), CCST(UK) Consultant Cardiothoracic Surgeon Normal Mitral Valve Function Mitral Regurgitation

More information

Echocardiographic variables associated with mitral regurgitation after aortic valve replacement for aortic valve stenosis

Echocardiographic variables associated with mitral regurgitation after aortic valve replacement for aortic valve stenosis The Egyptian Heart Journal (2013) 65, 135 139 Egyptian Society of Cardiology The Egyptian Heart Journal www.elsevier.com/locate/ehj www.sciencedirect.com ORIGINAL ARTICLE Echocardiographic variables associated

More information

Aortic Valve Stenosis: Flow and Gradient stratification and association with TAVR outcomes

Aortic Valve Stenosis: Flow and Gradient stratification and association with TAVR outcomes Aortic Valve Stenosis: Flow and Gradient stratification and association with TAVR outcomes Kostis Raisakis General Hospital of Athens «G. Gennimatas» Severe Aortic Stenosis Peak Velocity 4 m/s Up to 40%

More information

What are the best diagnostic tools to quantify aortic regurgitation?

What are the best diagnostic tools to quantify aortic regurgitation? What are the best diagnostic tools to quantify aortic regurgitation? Agnès Pasquet, MD, PhD Pôle de Recherche Cardiovasculaire Institut de Recherche Expérimentale et Clinique Université catholique de Louvain

More information

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer

«Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer «Paradoxical» low-flow, low-gradient AS with preserved LV function: A Silent Killer Philippe Pibarot, DVM, PhD, FACC, FAHA, FESC, FASE Canada Research Chair in Valvular Heart Diseases Université LAVAL

More information

Low Gradient Severe? AS

Low Gradient Severe? AS Low Gradient Severe? AS Philippe Pibarot, DVM, PhD, FACC, FAHA, FESC, FASE Canada Research Chair in Valvular Heart Diseases Institut Universitaire de Cardiologie et de Pneumologie de Québec / Québec Heart

More information

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL DISCLOSURES I WILL BE DISCUSSING OFF-LABEL USAGE OF DEVICES RELATED TO TMVR OBJECTIVES

More information

Echocardiography: Guidelines for Valve Quantification

Echocardiography: Guidelines for Valve Quantification Echocardiography: Guidelines for Echocardiography: Guidelines for Chamber Quantification British Society of Echocardiography Education Committee Richard Steeds (Chair), Gill Wharton (Lead Author), Jane

More information

Valvular heart disease: Patient needs and practice guidelines

Valvular heart disease: Patient needs and practice guidelines O P E N A C C E S S Review Article Valvular heart disease: Patient needs and practice guidelines Robert O. Bonow Center for Cardiovascular Innovation, Department of Medicine, Northwestern University Feinberg

More information

Importance of Exercise Capacity in Predicting Outcomes and Determining Optimal Timing of Surgery in Significant Primary Mitral Regurgitation

Importance of Exercise Capacity in Predicting Outcomes and Determining Optimal Timing of Surgery in Significant Primary Mitral Regurgitation Importance of Exercise Capacity in Predicting Outcomes and Determining Optimal Timing of Surgery in Significant Primary Mitral Regurgitation Peyman Naji, MD; Brian P. Griffin, MD; Tyler Barr; Fadi Asfahan,

More information

Severe aortic stenosis should be operated before symptom onset CONTRA. Helmut Baumgartner

Severe aortic stenosis should be operated before symptom onset CONTRA. Helmut Baumgartner Severe aortic stenosis should be operated before symptom onset CONTRA Helmut Baumgartner Westfälische Wilhelms-Universität Münster Adult Congenital and Valvular Heart Disease Center Dept. of Cardiology

More information

Introduction. Aims. Keywords Mitral regurgitation Echocardiography Left ventricular dysfunction Surgery

Introduction. Aims. Keywords Mitral regurgitation Echocardiography Left ventricular dysfunction Surgery European Journal of Echocardiography (2011) 12, 702 710 doi:10.1093/ejechocard/jer128 Predicting left ventricular dysfunction after valve repair for mitral regurgitation due to leaflet prolapse: additive

More information

Corrective Surgery in Severe Heart Failure. Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio

Corrective Surgery in Severe Heart Failure. Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio Corrective Surgery in Severe Heart Failure Jon Enlow, D.O., FACS Cardiothoracic Surgeon Riverside Methodist Hospital, Ohiohealth Columbus, Ohio Session Objectives 1.) Identify which patients with severe

More information

Mitral Valve Disease, When to Intervene

Mitral Valve Disease, When to Intervene Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages

More information

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts

More information

The Key Questions in Mitral Valve Interventions. Where Are We in 2018?

The Key Questions in Mitral Valve Interventions. Where Are We in 2018? The Key Questions in Mitral Valve Interventions Where Are We in 2018? Gilles D. DREYFUS, MD, FRCS, FESC Professor of Cardiothoracic Surgery 30 GIORNATE CARDIOLOGICHE TORINESI - OCT 2018 Are guidelines

More information

Secondary MR joint with the mitral academy. What is new in our understanding of this disease? Luc Pierard University Hospital, Liège

Secondary MR joint with the mitral academy. What is new in our understanding of this disease? Luc Pierard University Hospital, Liège Secondary MR joint with the mitral academy What is new in our understanding of this disease? Luc Pierard University Hospital, Liège Faculty disclosure Luc Pierard I have no financial relationships to disclose.

More information

Aortic stenosis with concomitant mitral regurgitation

Aortic stenosis with concomitant mitral regurgitation Challenges in the evaluation and management of aortic stenosis Aortic stenosis with concomitant mitral regurgitation S1 Philippe Unger, M.D., FESC Erasme Hospital - Université Libre de Bruxelles Brussels,

More information

The role of exercise echocardiography in the management of mitral valve disease

The role of exercise echocardiography in the management of mitral valve disease Neth Heart J (2013) 21:487 496 DOI 10.1007/s12471-013-0452-5 ORIGINAL ARTICLE E-LEARNING The role of exercise echocardiography in the management of mitral valve disease R. Jansen & P. A. M. Kracht & M.

More information

Introduction. Original Article

Introduction. Original Article Original Article Exercise capacity in asymptomatic patients with significant primary mitral regurgitation: independent effect of global longitudinal left ventricular strain Amgad Mentias, Alaa Alashi,

More information

Nikos Kouris a, *, Ignatios Ikonomidis b, Dimitra Kontogianni a, Peter Smith b, Petros Nihoyannopoulos b

Nikos Kouris a, *, Ignatios Ikonomidis b, Dimitra Kontogianni a, Peter Smith b, Petros Nihoyannopoulos b Eur J Echocardiography (2005) 6, 435e442 Mitral valve repair versus replacement for isolated non-ischemic mitral regurgitation in patients with preoperative left ventricular dysfunction. A long-term follow-up

More information

The Edge-to-Edge Technique f For Barlow's Disease

The Edge-to-Edge Technique f For Barlow's Disease The Edge-to-Edge Technique f For Barlow's Disease Ottavio Alfieri, Michele De Bonis, Elisabetta Lapenna, Francesco Maisano, Lucia Torracca, Giovanni La Canna. Department of Cardiac Surgery, San Raffaele

More information

Aortic stenosis (AS) is common with the aging population.

Aortic stenosis (AS) is common with the aging population. New Insights Into the Progression of Aortic Stenosis Implications for Secondary Prevention Sanjeev Palta, MD; Anita M. Pai, MD; Kanwaljit S. Gill, MD; Ramdas G. Pai, MD Background The risk factors affecting

More information

Michigan Society of Echocardiography 30 th Year Jubilee

Michigan Society of Echocardiography 30 th Year Jubilee Michigan Society of Echocardiography 30 th Year Jubilee Stress Echocardiography in Valvular Heart Disease Moving Beyond CAD Karthik Ananthasubramaniam, MD FRCP (Glas) FACC FASE FASNC Associate Professor

More information

Outcome of elderly patients with severe but asymptomatic aortic stenosis

Outcome of elderly patients with severe but asymptomatic aortic stenosis Outcome of elderly patients with severe but asymptomatic aortic stenosis Robert Zilberszac, Harald Gabriel, Gerald Maurer, Raphael Rosenhek Department of Cardiology Medical University of Vienna ESC Congress

More information

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention John N. Hamaty D.O. FACC, FACOI November 17 th 2017 I have no financial disclosures Primary Mitral

More information

Left atrial function. Aliakbar Arvandi MD

Left atrial function. Aliakbar Arvandi MD In the clinic Left atrial function Abstract The left atrium (LA) is a left posterior cardiac chamber which is located adjacent to the esophagus. It is separated from the right atrium by the inter-atrial

More information

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated? RM Suri, V Sharma, JA Dearani, HM Burkhart, RC Daly, LD Joyce, HV Schaff Division of Cardiovascular Surgery, Mayo Clinic, Rochester,

More information

Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations

Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations Imaging and Diagnostic Testing Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations Jae-Jin Kwak, MD, a Yong-Jin

More information

Understanding the guidelines for Interventions in MR. Ali AlMasood

Understanding the guidelines for Interventions in MR. Ali AlMasood Understanding the guidelines for Interventions in MR Ali AlMasood Mitral regurgitation The most diverse from all acquired valve diseases About 50% of patients with an LVEF 35 percent had moderate to severe

More information

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II SURGICAL RISK IN VALVULAR HEART DISEASE: WHAT 2D AND 3D ECHO CAN TELL YOU AND WHAT THEY CAN'T Ernesto E Salcedo, MD Professor of Medicine University of Colorado School of Medicine Director of Echocardiography

More information

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT)

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) UNIVERSITY OF PADUA, SCHOOL OF MEDICINE Department of Cardiac,Thoracic and Vascular Sciences Padua, Italy MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) Luigi P. Badano**, MD, PhD, FESC,

More information

Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid

Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid Reshape/Coapt: do we need more? Prof. J Zamorano Head of Cardiology University Hospital Ramon y Cajal, Madrid Patient records 76 y.o. male Hypertension. Dyslipidemia. OPLD. Smoked in the past. Diabetes

More information

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension ESC Congress 2011.No 85975 Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension Second Department of Internal

More information